The purpose of this guideline is to ensure the best treatment for adults with suspected or confirmed pneumonia in the community during the COVID-19 pandemic and best use of NHS resources. We have withdrawn our guideline on diagnosing and managing pneumonia in adults until further notice....
The purpose of this guideline is to provide recommendations for managing COVID‑19 symptoms for patients in the community, including at the end of life. It also includes recommendations about managing medicines for these patients, and protecting staff from infection....
Multiple questions have been raised regarding the gastrointestinal and liver manifestations of COVID-19 infection, and implications of SARS-CoV-2 infection on gastrointestinal endoscopy. A joint society statement of the American Gastroenterological Association (AGA), the American Association for the Stud...
The purpose of this document is to provide a basis for advice to clinicians on the use of the currently available antivirals for patients presenting with illness due to influenza virus infection, as well their use for chemoprophylaxis. This guidance updates and replaces the recommendations published in A...
Influenza A Virus, H1N1 Subtype,
Pandemics,
Oseltamivir/administration & dosage,
Influenza, Human/epidemiology,
Risk Groups,
Influenza, Human/drug therapy,
Antiviral Agents/administration & dosage,
Zanamivir/administration & dosage
This revised guidance is published in two parts. Part II documents the procedures followed in developing this guidance, together with a review of evidence and other new information on the pharmacological agents considered....
Pandemics,
Influenza A Virus, H1N1 Subtype,
Influenza, Human/drug therapy,
RNA Virus Infections/drug therapy,
Oseltamivir/administration & dosage,
Zanamivir/administration & dosage,
Amantadine/administration & dosage,
Rimantadine/administration & dosage,
Ribavirin/administration & dosage,
Antiviral Agents/administration & dosage
Pandemic (H1N1) 2009, the first influenza pandemic of the 21st century, reached all parts of the world within a year, causing epidemics of varying magnitude. During the pandemic period, the World Health Organization (WHO) received reports of over 18 000 laboratory-confirmed deaths due to infection with t...
Communicable diseases are currently the leading cause of preventable deaths worldwide, disproportionately affecting resource-poor settings. Pandemic influenza would add to already unacceptable levels of morbidity and mortality from diarrhoea, malaria, pneumonia, malnutrition, HIV/AIDS and tuberculosis, i...
